DOSSIER · 13F Holders · Q2 2026
APUS
APIMEDS PHARMACEUTICALS US I
7 institutions still hold APIMEDS PHARMACEUTICALS US I as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 03771D102·7 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
7 institutions reported APUS in Q2 2026. Hemenway Trust Co LLC leads at 66.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.